Status:
UNKNOWN
Testing the Use of Interoceptive Exposure to Reduce Barriers to Psychotherapy
Lead Sponsor:
G.V. (Sonny) Montgomery VA Medical Center
Conditions:
Anxiety
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
To assess the effectiveness of Interoceptive Exposure (IE) as a treatment to reduce negative cognitions and arousal in a veteran sample during an anxiety-inducing situation (i.e., the Trier Social Str...
Eligibility Criteria
Inclusion
- Interested OEF/OIF veterans with a reported history of combat-related trauma, probable PTSD diagnosis (score above 44 on the PTSD Checklist), scores above 28 on the Anxiety Sensitivity Index (ASI), and who have been medically cleared will be invited to participate (study personnel will assist the participant in getting clearance from their primary care physician or TRP staff).
Exclusion
- Veterans will be excluded if they are judged to have medical conditions that might limit cooperation or compromise the integrity of the self-report or psychophysiological data (e.g., uncontrolled blood pressure, severe asthma, dementia, psychotic disorder, acute mania, current substance abuse, or taking medications that would reduce physiological responding). Veterans who are currently receiving (or who are scheduled to begin) individual exposure-based treatment for PTSD will be excluded from the study. As this project is designed as a pilot study, no exclusions will be made based on previous treatment or previous treatment refusal; however, treatment history data will be collected.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00795379
Start Date
November 1 2008
Last Update
November 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
G.V. (Sonny) Montgomery VAMC
Jackson, Mississippi, United States, 39216